Published in J Am Coll Cardiol on September 01, 2000
Effects of simvastatin on cardiac neural and electrophysiologic remodeling in rabbits with hypercholesterolemia. Heart Rhythm (2008) 1.49
Parasympathetic response in chick myocytes and mouse heart is controlled by SREBP. J Clin Invest (2008) 1.04
Lipid-lowering therapy in older persons. Arch Med Sci (2015) 0.82
C-reactive protein in arrhythmogenic right ventricular dysplasia/cardiomyopathy and relationship with ventricular tachycardia. Cardiol Res Pract (2010) 0.81
Increased inducibility of ventricular tachycardia and decreased heart rate variability in a mouse model for type 1 diabetes: effect of pravastatin. Am J Physiol Heart Circ Physiol (2013) 0.80
Potential autonomic nervous system effects of statins in heart failure. Heart Fail Clin (2008) 0.78
The role of F18-fluorodeoxyglucose positron emission tomography in identifying patients at high risk for lethal arrhythmias from cardiac sarcoidosis and the use of serial scanning to guide therapy. Int J Cardiovasc Imaging (2013) 0.77
The influence of atorvastatin on parameters of inflammation left ventricular function, hospitalizations and mortality in patients with dilated cardiomyopathy--5-year follow-up. Lipids Health Dis (2013) 0.76
Prevention of recurrent life-threatening arrhythmias: will lipid-lowering therapy make a difference? J Am Coll Cardiol (2000) 0.75
C-reactive protein levels in the brugada syndrome. Cardiol Res Pract (2011) 0.75
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J (2003) 17.80
Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J (1994) 4.02
Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis (1998) 3.50
Rotating shift work and the metabolic syndrome: a prospective study. Int J Epidemiol (2009) 2.60
Belgian heart disease prevention project: incidence and mortality results. Lancet (1983) 2.23
Report of a study group on ablate and pace therapy for paroxysmal atrial fibrillation. Barcelona Discussion Group. Working Group on Arrhythmias of the European Society of Cardiology. Europace (1999) 2.08
Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. J Hypertens (1998) 1.80
Screening of family members of patients with premature coronary heart disease; results from the EUROASPIRE II family survey. Eur Heart J (2003) 1.77
Atrioverter: an implantable device for the treatment of atrial fibrillation. Circulation (1998) 1.74
Job conditions and fibrinogen in 14226 Belgian workers: the Belstress study. Eur Heart J (2002) 1.68
Prognostic value of ECG findings for total, cardiovascular disease, and coronary heart disease death in men and women. Heart (1998) 1.68
Conversion of atrial fibrillation to sinus rhythm and rate control by digoxin in comparison to placebo. Eur Heart J (1997) 1.64
Stronger associations between daily mortality and fine particulate air pollution in summer than in winter: evidence from a heavily polluted region in western Europe. J Epidemiol Community Health (2007) 1.52
Blood pressure load determines left ventricular mass in essential hypertension. Int J Cardiol (1992) 1.47
Determinants of sudden death after discharge from hospital for myocardial infarction in the thrombolytic era. Eur Heart J (2001) 1.46
Overweight and obesity: a major challenge for coronary heart disease secondary prevention in clinical practice in Europe. Eur Heart J (2000) 1.45
Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart J (1998) 1.44
Changes in the QT interval and its adaptation to rate, assessed with continuous electrocardiographic recordings in patients with ventricular fibrillation, as compared to normal individuals without arrhythmias. Eur Heart J (1997) 1.43
Perceived job stress and incidence of coronary events: 3-year follow-up of the Belgian Job Stress Project cohort. Am J Epidemiol (2005) 1.42
An equine model of chronic atrial fibrillation: methodology. Vet J (2002) 1.42
Cardiac anatomy and diastolic filling in professional road cyclists. Eur J Appl Physiol Occup Physiol (1993) 1.41
Intravenous amiodarone treatment in horses with chronic atrial fibrillation. Vet J (2006) 1.41
Laser-assisted lead extraction: the European experience. Europace (2007) 1.41
Prevalences of ECG findings in large population based samples of men and women. Heart (2000) 1.40
Protection against ischemic heart disease in the Belgian Physical Fitness Study: physical fitness rather than physical activity? Am J Epidemiol (1987) 1.40
Ankle/arm pressure index in asymptomatic middle-aged males: an independent predictor of ten-year coronary heart disease mortality. Angiology (1995) 1.40
[Aberrant origin of the left coronary artery from the pulmonary artery as cause of ventricular fibrillation in a young woman]. Ned Tijdschr Geneeskd (1993) 1.39
Estimation of brain lesion size based on quantifying CK-BB release. Clin Chem (1990) 1.39
Chronic diseases and calls to action. Int J Epidemiol (2009) 1.37
Variations of autonomic tone preceding onset of atrial fibrillation after coronary artery bypass grafting. Am J Cardiol (1998) 1.26
Task Force II: blood pressure measurement and cardiovascular outcome. Blood Press Monit (2001) 1.18
Haptoglobin polymorphism, iron metabolism and mortality in HIV infection. AIDS (1998) 1.14
The pattern of food and mortality in Belgium. Lancet (1977) 1.13
ICDs at higher age and clinical risk factors. Neth Heart J (2014) 1.13
[Evaluation of technics used to define type 'A' pattern, in the Belgian Prevention Project of cardiovascular diseases (author's transl)]. Rev Epidemiol Sante Publique (1977) 1.10
Heart rate dynamics before spontaneous onset of ventricular fibrillation in patients with healed myocardial infarcts. Am J Cardiol (1999) 1.10
HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk. Atherosclerosis (2009) 1.10
Recent findings on return to work after an acute myocardial infarction or coronary artery bypass grafting. Acta Cardiol (2000) 1.10
Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Atherosclerosis (1994) 1.09
The role of remote monitoring in the reduction of inappropriate implantable cardioverter defibrillator therapies. Clin Res Cardiol (2006) 1.09
Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis. Circulation (2001) 1.08
Association between leisure time physical activity and markers of chronic inflammation related to coronary heart disease. Atherosclerosis (2004) 1.07
Post-cardiac injury syndrome and an increased humoral immune response against the major contractile proteins (actin and myosin). Am J Cardiol (1985) 1.07
Apolipoprotein E serum concentration and polymorphism in six European countries: the ApoEurope Project. Atherosclerosis (2000) 1.06
Breakfast habits affect overall nutrient profiles in adolescents. Public Health Nutr (2007) 1.06
Spontaneous episodes of atrial fibrillation after implantation of the Metrix Atrioverter: observations on treated and nontreated episodes. Metrix Investigators. J Am Coll Cardiol (2000) 1.06
Differential contribution of testosterone and estradiol in the determination of cholesterol and lipoprotein profile in healthy middle-aged men. Atherosclerosis (2003) 1.05
Numerical validation of a new method to assess aortic pulse wave velocity from a single recording of a brachial artery waveform with an occluding cuff. Ann Biomed Eng (2010) 1.05
ECG changes and plasma concentrations of propafenone and its metabolites in a case of severe poisoning. J Toxicol Clin Toxicol (1998) 1.04
Heart rate dynamics at the onset of ventricular tachyarrhythmias as retrieved from implantable cardioverter-defibrillators in patients with coronary artery disease. Circulation (2000) 1.03
Occupational stress and incidence of sick leave in the Belgian workforce: the Belstress study. J Epidemiol Community Health (2004) 1.01
The Belgian heart disease prevention project. Modification of the coronary risk profile in an industrial population. Circulation (1980) 1.01
The predictive value of electrocardiographic abnormalities for total and cardiovascular disease mortality in men and women. Eur Heart J (1994) 1.01
Comparison of athletes with life-threatening ventricular arrhythmias with two groups of healthy athletes and a group of normal control subjects. Am J Cardiol (1994) 1.00
The Belgian Heart Disease Prevention Project: type "A" behavior pattern and the prevalence of coronary heart disease. Psychosom Med (1981) 1.00
Electrocardiographic and morphometric features in patients with ventricular tachycardia of right ventricular origin. Heart (1998) 1.00
Comparison of monophasic and biphasic shocks for transthoracic cardioversion of atrial fibrillation. Heart (2003) 1.00
Discriminative value of lipids and apoproteins in coronary heart disease. Atherosclerosis (1982) 0.99
Associations between haptoglobin polymorphism, lipids, lipoproteins and inflammatory variables. Atherosclerosis (1999) 0.99
Normal reference values for creatine, creatinine, and carnitine are lower in vegetarians. Clin Chem (1989) 0.99
Initial clinical experience with a new arrhythmia detection algorithm in dual chamber implantable cardioverter defibrillators. Europace (2001) 0.98
Evaluation of transesophageal echocardiography as a diagnostic and therapeutic aid in a critical care setting. Chest (1995) 0.98
The epidemiology of low serum pepsinogen A levels and an international association with gastric cancer rates. EUROGAST Study Group. Gastroenterology (1994) 0.98
Haptoglobin polymorphism as a risk factor for coronary heart disease mortality. Atherosclerosis (2001) 0.96
Long-term performance of the St Jude Riata 1580-1582 ICD lead family. Neth Heart J (2013) 0.96
Estimated energy intake, macronutrient intake and meal pattern of Flemish adolescents. Eur J Clin Nutr (2003) 0.95
Misclassification of coronary heart disease in mortality statistics. Evidence from the WHO-MONICA Ghent-Charleroi Study in Belgium. J Epidemiol Community Health (1998) 0.94
Management of familial hypercholesterolemia in children and young adults: consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization. Atherosclerosis (2011) 0.94
Plasma apolipoprotein concentrations in young adults with a parental history of premature coronary heart disease and in control subjects. The EARS Study. European Atherosclerosis Research Study. Circulation (1994) 0.94
Aldosterone and vascular damage. Curr Hypertens Rep (2000) 0.93
Evaluation of six minute walking test in patients with single chamber rate responsive pacemakers. Br Heart J (1994) 0.93
Regional differences in risk factor distributions, food habits and coronary heart disease mortality and morbidity in Belgium. Int J Epidemiol (1979) 0.93
Transesophageal echocardiography for insertion of a physiological pacemaker in early pregnancy. Pacing Clin Electrophysiol (1990) 0.92
Parameters of inflammation and infection in a community based case-control study of coronary heart disease. Atherosclerosis (2002) 0.92
The Belgian heart disease prevention project: changes in smoking habits after two years of intervention. Prev Med (1980) 0.92
Maternal and umbilical fatty acid status in relation to maternal diet. Prostaglandins Leukot Essent Fatty Acids (2002) 0.92
Obesity, body fat distribution and incidence of sick leave in the Belgian workforce: the Belstress study. Int J Obes Relat Metab Disord (2004) 0.91
Type A in relation to job-stress, social and bioclinical variables: the Belgian Physical Fitness Study. J Human Stress (1983) 0.91
Biosurfactants are involved in the biological control of Verticillium microsclerotia by Pseudomonas spp. J Appl Microbiol (2007) 0.91
Postprandial response to a fat tolerance test in young adults with a paternal history of premature coronary heart disease - the EARS II study (European Atherosclerosis Research Study). Eur J Clin Invest (2000) 0.91
Noninvasive assessment of left ventricular and myocardial contractility in middle-aged men and women: disparate evolution above the age of 50? Am J Physiol Heart Circ Physiol (2007) 0.91
Recommendations for driving of patients with implantable cardioverter defibrillators. Study Group on 'ICD and Driving' of the Working Groups on Cardiac Pacing and Arrhythmias of the European Society of Cardiology. Eur Heart J (1997) 0.91
Haptoglobin polymorphism and peripheral arterial occlusive disease. Atherosclerosis (1999) 0.91
Long term results of cardioverter-defibrillator implantation in patients with right ventricular dysplasia and malignant ventricular tachyarrhythmias. Heart (2001) 0.91
Fast determination of haptoglobin phenotype and calculation of hemoglobin binding capacity using high pressure gel permeation chromatography. Clin Chim Acta (2000) 0.90
Effects of a low-intensity worksite-based nutrition intervention. Occup Med (Lond) (1999) 0.90
Is low serum chloride level a risk factor for cardiovascular mortality? J Cardiovasc Risk (1998) 0.90
Age- and gender-specific differences in left ventricular cardiac function and volumes determined by gated SPET. Eur J Nucl Med (2001) 0.90
Health care utilisation after defibrillator implantation for primary prevention according to the guidelines in 2 Dutch academic medical centres. Neth Heart J (2011) 0.89
The relationship between diet and subclinical atherosclerosis: results from the Asklepios Study. Eur J Clin Nutr (2011) 0.89
Acute success and short-term follow-up of catheter ablation of isthmus-dependent atrial flutter; a comparison of 8 mm tip radiofrequency and cryothermy catheters. J Interv Card Electrophysiol (2008) 0.89
Psychological status and the role of coping style after coronary artery bypass graft surgery. Results of a prospective study. Qual Life Res (2001) 0.88